Idexx Laboratories
(IDXX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 159,229 | 187,675 | 169,019 | 165,975 | 160,408 |
| Marketable Securities | 0 | 284,255 | 285,085 | 256,923 | 239,933 |
| Receivables | 259,865 | 234,597 | 228,159 | 240,262 | 225,353 |
| Inventories | 179,039 | 164,318 | 176,749 | 169,693 | 172,183 |
| Other current assets | 103,574 | 101,140 | 83,710 | 85,805 | 80,711 |
| TOTAL | $701,707 | $971,985 | $942,722 | $918,658 | $878,588 |
| Non-Current Assets | |||||
| PPE Net | 384,246 | 379,096 | 367,513 | 364,779 | 361,233 |
| Intangibles | 41,893 | 243,719 | 45,251 | 242,759 | 226,287 |
| Other Non-Current Assets | 341,646 | 118,616 | 313,848 | 110,941 | 105,983 |
| TOTAL | $767,785 | $741,431 | $726,612 | $718,479 | $693,503 |
| Total Assets | $1,469,492 | $1,713,416 | $1,669,334 | $1,637,137 | $1,572,091 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 70,409 | 66,968 | 60,583 | 58,606 | 62,249 |
| Accrued Expenses | 210,384 | 253,418 | 220,507 | 210,181 | 174,763 |
| TOTAL | $728,838 | $1,004,567 | $996,543 | $1,001,493 | $936,077 |
| Non-Current Liabilities | |||||
| Long Term Debt | 609,005 | 606,075 | 604,149 | 600,891 | 594,868 |
| Deferred Revenues | 40,545 | 29,181 | 29,203 | 28,706 | 28,065 |
| Other Non-Current Liabilities | 84,548 | 95,685 | 49,580 | 49,180 | 41,981 |
| TOTAL | $789,636 | $762,691 | $721,182 | $721,751 | $709,926 |
| Total Liabilities | $1,518,474 | $1,767,258 | $1,717,725 | $1,723,244 | $1,646,003 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,863 | 87,123 | 87,219 | 87,276 | 88,123 |
| Common Shares | 10,468 | 10,428 | 10,412 | 10,395 | 10,374 |
| Retained earnings | 880,348 | 803,545 | 765,288 | 694,777 | 609,420 |
| Other shareholders' equity | -27,957 | -29,746 | -28,780 | -31,752 | -32,853 |
| TOTAL | $-48,982 | $-53,842 | $-48,391 | $-86,107 | $-73,912 |
| Total Liabilities And Equity | $1,469,492 | $1,713,416 | $1,669,334 | $1,637,137 | $1,572,091 |